KAYLA HAINES: Open Payments
NPI 1598217499 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 36 payments from 20 companies in 2025. Trend: 2023 $5,816 · 2024 $3,727 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $128 |
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| Novartis Pharmaceuticals Corporation | 3 | $86 |
| Celgene Corporation | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Astellas Pharma US Inc | 2 | $45 |
| PFIZER INC. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
Products named: KEYTRUDA, XTANDI, OPDIVO, NINLARO, PLUVICTO, LIBTAYO, LUTATHERA, Itovebi.
Industry payments across FL — which companies pay providers there.
